Carbapenem resistance and mortality in pediatric Acinetobacter bloodstream infections: determinants from a 12-year tertiary-care cohort study

Suleyman Emre Karauzum Ece Erci G. Koc Pınar Yazıcı Özkaya E. Kıran Taşçı Miray Karakoyun G. Ozek E. Ataseven D. Terek Melike Yaşar-Duman Fatma Feriha Çilli Zümrüt Şahbudak Bal Gulhadiye Avcu

Oct 2026 · European Journal of Pediatrics · Vol 185 · 0 citations · 38 references

Medicine

TL;DR

Thrombocytopenia and carbapenem resistance were associated with 30-day all-cause mortality in the primary adjusted analysis; the resistance association was not statistically significant in A. baumannii-restricted and first-episode-only sensitivity analyses.

DOI PubMed Semantic Scholar

View source

Similar papers

Open access Oct 2026

Clinical factors associated with carbapenem resistance and in-hospital mortality in Klebsiella pneumoniae bloodstream infection: a 7-year retrospective cohort study

Background Carbapenem-resistant Klebsiella pneumoniae bloodstream infection (CRKP BSI) is associated with substantial mortality and limited therapeutic options, yet institutional epidemiology and risk profiles vary. We evaluated antimicrobial susceptibility, non-blood-site detection, factors associated with carbapenem...

Na Xu, Yi Liang, Wen Zhu et al. · Frontiers in Microbiology · 0 citations

Open access Oct 2026

Carbapenem-Resistant Acinetobacter baumannii Isolation and In-Hospital Mortality in Adults Hospitalized with COVID-19 in Romania: A Retrospective Single-Center Cohort Study

CRAB isolation was associated with higher in-hospital mortality after adjustment for baseline severity, but selective sampling precludes causal inference, which suggests early detection suggests frequent carriage on admission.

Cristiana Georgeta Bujor, Marilena Dinuți, Felicia Sfrijan · Journal of Clinical Medicine · 0 citations

Oct 2026

Clinical burden and outcomes of pediatric carbapenem-resistant Klebsiella pneumoniae bloodstream infections in a tertiary care center.

Prior carbapenem exposure and longer antibiotic use were more frequent in the CRKP group, although the differences were not statistically significant, and white blood cell, neutrophil, lymphocyte, and platelet counts were significantly lower in patients with CRKP BSI.

Sevliya Ocal Demir, Seyhan Yılmaz, Meryem Çağla Abacı Çapar et al. · European Journal of Clinical... · 0 citations

Open access Sep 2026

Ceftazidime–Avibactam Versus Colistin-Based Regimens for Carbapenem-Resistant Enterobacterales Bloodstream Infections: A Six-Year Retrospective Cohort and 30-Day Mortality Analysis

The association between Vasopressor requirement, viral pneumonia and bacterial respiratory infection were independently associated with death, whereas definitive ceftazidime/avibactam with or without aztreonam (C/AVI ± AZT) was associated with lower mortality.

Victor-Pierre Ormeneanu, Anca Zanfirescu, Corina Andrei et al. · Microorganisms · 0 citations

Open access Sep 2026

Risk factors associated with carbapenem-resistant Gram-negative bacterial infections in intensive care units in Jordan

Carbapenem-resistant Gram-negative bacteria (CR-GNB) pose major challenges in intensive care units (ICUs) due to limited treatment options and high mortality. Data describing their predictors in Jordan are scarce. This study aimed to identify risk factors associated with CR-GNB infections among ICU patients. A retrospe...

Mohammad H. Gharaibeh, O. Sayyouh, M. El-Shokry et al. · BMC Infectious Diseases · 0 citations

Sep 2026

Risk Factors for Extended-Spectrum β-lactamase, Carbapenem, and Colistin Resistance Among Enterobacterales Bloodstream Infections in Intensive Care Units.

Enterobacterales bloodstream infections (E-BSIs) in intensive care units (ICUs) are increasingly complicated by antimicrobial resistance. This retrospective study evaluated resistance patterns and phenotype-specific risk factors for extended-spectrum β-lactamase (ESBL) production and carbapenem and colistin resistance...

Fahriye Melis Gürsoy Kurtoğlu, A. Altunsoy, Sümeyye Nur Aydın et al. · Microbial Drug Resistance · 0 citations